Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype

Aino‐Maija Leppä(German Cancer Research Center), Karen Grimes(European Molecular Biology Laboratory), Hyobin Jeong(Yonsei University), Frank Y. Huang(German Cancer Research Center), Álvaro Andrades(European Molecular Biology Laboratory), Alexander Waclawiczek(German Cancer Research Center), Tobias Boch(Heidelberg University), Anna Jauch(Heidelberg University), Simon Renders(German Cancer Research Center), Patrick Stelmach(German Cancer Research Center), Carsten Müller‐Tidow(Heidelberg University), Darja Karpova(German Cancer Research Center), Markus Sohn(German Cancer Research Center), Florian Grünschläger(German Cancer Research Center), Patrick Hasenfeld(European Molecular Biology Laboratory), Eva Benito Garagorri(European Molecular Biology Laboratory), Vera Thiel(German Cancer Research Center), Anna Dolnik(Charité - Universitätsmedizin Berlin), Bernardo Rodríguez–Martín(European Molecular Biology Laboratory), Lars Bullinger(Charité - Universitätsmedizin Berlin), Krzysztof Mrózek(The Ohio State University), Ann‐Kathrin Eisfeld(The Ohio State University), Alwin Krämer(German Cancer Research Center), Ashley D. Sanders(Max Delbrück Center), Jan O. Korbel(German Cancer Research Center), Andreas Trumpp(German Cancer Research Center)
Nature Genetics
November 25, 2024
Cited by 30Open Access
Full Text

Abstract

Chromosomal instability is a major driver of intratumoral heterogeneity (ITH), promoting tumor progression. In the present study, we combined structural variant discovery and nucleosome occupancy profiling with transcriptomic and immunophenotypic changes in single cells to study ITH in complex karyotype acute myeloid leukemia (CK-AML). We observed complex structural variant landscapes within individual cells of patients with CK-AML characterized by linear and circular breakage-fusion-bridge cycles and chromothripsis. We identified three clonal evolution patterns in diagnosis or salvage CK-AML (monoclonal, linear and branched polyclonal), with 75% harboring multiple subclones that frequently displayed ongoing karyotype remodeling. Using patient-derived xenografts, we demonstrated varied clonal evolution of leukemic stem cells (LSCs) and further dissected subclone-specific drug-response profiles to identify LSC-targeting therapies, including BCL-xL inhibition. In paired longitudinal patient samples, we further revealed genetic evolution and cell-type plasticity as mechanisms of disease progression. By dissecting dynamic genomic, phenotypic and functional complexity of CK-AML, our findings offer clinically relevant avenues for characterizing and targeting disease-driving LSCs.


Related Papers

No related papers found

Powered by citation graph analysis